Veraxa Biotech Holding AG (VRXA) Total Non-Current Liabilities (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has 2 years of Total Non-Current Liabilities data on file, last reported at $112.6 million in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 92.74% year-over-year to $112.6 million in Q4 2025; TTM through Dec 2025 was $112.6 million, a 92.74% increase from a year earlier, with the FY2025 full-year figure at $112.6 million, up 92.74% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $112.6 million, up from $58.4 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for VRXA reached as high as $112.6 million in Q4 2025 and fell as low as $58.4 million in Q4 2024.